Cosponsor
Insufficient evidenceCosponsorship · Reviewed automated analysis
Compared with: expand access to health care for all
The cited action is cosponsorship of the FDA Modernization Act 3.0, which concerns FDA regulatory language and alternatives to animal testing in investigational drug applications. That is too indirect to assess a specific policy goal of expanding access to health care for all. The available passages do not show a direct mechanism increasing health care coverage, affordability, or service access, nor do they show a clear substantive restriction on that goal.
“Adam also is a supporter of universal healthcare and continues to fight for expanded access to health care for all.”
Official statement · Captured 2026-10-28
Official legislative summarySummary-based analysis · Action predates captured statement
Assessed 2026-10-28 · Review: User-authorized automated publication. Published at the user request after the bounded production backfill. Automated evidence validation passed; comparisons have not been individually audited.
“FDA Modernization Act 3.0 This bill requires the Food and Drug Administration (FDA) to publish an interim final rule implementing a provision of the Consolidated Appropriations Act of 2023 that authorized the use of certain alternatives to animal testing to support investigational use of a new drug.”Official summary source
